[
  {
    "date": "2023-12-30",
    "symbol": "SNYNF",
    "period": "FY",
    "documenttype": "20-F",
    "documentregistrationstatement": "false",
    "documentannualreport": "true",
    "currentfiscalyearenddate": "--12-31",
    "documentperiodenddate": "2023-12-31",
    "documenttransitionreport": "false",
    "documentshellcompanyreport": "false",
    "entityfilenumber": "001-31368",
    "entityregistrantname": "Sanofi",
    "entityincorporationstatecountrycode": "I0",
    "contactpersonnelname": "Roy Papatheodorou",
    "entityaddressaddressline1": "46, avenue de la Grande Armée",
    "entityaddresspostalzipcode": 75017,
    "entityaddresscityortown": "Paris",
    "entityaddresscountry": "FR",
    "cityareacode": 33,
    "localphonenumber": "1 53 77 40 00",
    "security12btitle": "American Depositary Shares, each representing one half of one ordinary share, par value €2 per share",
    "tradingsymbol": "SNY",
    "securityexchangename": "NASDAQ",
    "entitycommonstocksharesoutstanding": 1264799969,
    "entitywellknownseasonedissuer": "Yes",
    "entityvoluntaryfilers": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityinteractivedatacurrent": "Yes",
    "entityfilercategory": "Large Accelerated Filer",
    "entityemerginggrowthcompany": "false",
    "icfrauditorattestationflag": "true",
    "documentfinstmterrorcorrectionflag": "false",
    "documentaccountingstandard": "International Financial Reporting Standards",
    "entityshellcompany": "false",
    "amendmentflag": "false",
    "documentfiscalyearfocus": 2023,
    "documentfiscalperiodfocus": "FY",
    "entitycentralindexkey": 1121404,
    "auditorname": "PricewaterhouseCoopers Audit",
    "auditorlocation": "Neuilly-sur-Seine",
    "auditorfirmid": 1347,
    "propertyplantandequipment": 10160000000,
    "rightofuseassets": 1654000000,
    "goodwill": 49404000000,
    "intangibleassetsotherthangoodwill": 24319000000,
    "investmentaccountedforusingequitymethod": 424000000,
    "othernoncurrentassets": 3218000000,
    "currenttaxassetsnoncurrent": 188000000,
    "deferredtaxassets": 6427000000,
    "noncurrentassets": 95794000000,
    "inventories": 9666000000,
    "currenttradereceivables": 8433000000,
    "othercurrentassets": 3455000000,
    "currenttaxassetscurrent": 391000000,
    "cashandcashequivalents": 8710000000,
    "currentassetsotherthanassetsordisposalgroupsclassifiedasheldforsaleorasheldfordistributiontoowners": 30655000000,
    "noncurrentassetsordisposalgroupsclassifiedasheldforsale": 15000000,
    "assets": 126464000000,
    "equityattributabletoownersofparent": 74040000000,
    "noncontrollinginterests": 313000000,
    "equity": 74353000000,
    "longtermborrowings": 14347000000,
    "noncurrentleaseliabilities": 1755000000,
    "noncurrentliabilitiesrelatedtobusinesscombinationsandtononcontrollinginterests": 501000000,
    "noncurrentprovisionsandothernoncurrentliabilities": 7602000000,
    "currenttaxliabilitiesnoncurrent": 1842000000,
    "deferredtaxliabilities": 1857000000,
    "noncurrentliabilities": 27904000000,
    "tradeandothercurrentpayablestotradesuppliers": 7328000000,
    "currentliabilitiesrelatedtobusinesscombinationsandtononcontrollinginterests": 208000000,
    "currentprovisionsandothercurrentliabilities": 13741000000,
    "currenttaxliabilitiescurrent": 597000000,
    "currentleaseliabilities": 275000000,
    "currentborrowingsandcurrentportionofnoncurrentborrowings": 2045000000,
    "currentliabilitiesotherthanliabilitiesincludedindisposalgroupsclassifiedasheldforsale": 24194000000,
    "liabilitiesincludedindisposalgroupsclassifiedasheldforsale": 13000000,
    "equityandliabilities": 126464000000,
    "revenuefromsaleofgoods": 43070000000,
    "otherrevenue": 3374000000,
    "costofsales": 14236000000,
    "grossprofit": 32208000000,
    "researchanddevelopmentexpense": 6728000000,
    "sellinggeneralandadministrativeexpense": 10692000000,
    "miscellaneousotheroperatingincome": 1292000000,
    "miscellaneousotheroperatingexpense": 3516000000,
    "amortisationintangibleassetsotherthangoodwill": 2172000000,
    "impairmentlossrecognisedinprofitorlossintangibleassetsotherthangoodwill": 896000000,
    "increasedecreaseincontingentconsiderationassetliability": 93000000,
    "expenseofrestructuringactivities": 1490000000,
    "othergainslossesandlitigation": -38000000,
    "profitlossfromoperatingactivities": 7875000000,
    "financecosts": 1313000000,
    "financeincome": 591000000,
    "incomebeforetaxandinvestmentsaccountedforequitymethodinvestments": 7153000000,
    "incometaxexpensecontinuingoperations": 1602000000,
    "shareofprofitlossofassociatesaccountedforusingequitymethod": -115000000,
    "profitloss": 5436000000,
    "profitlossattributabletononcontrollinginterests": 36000000,
    "profitlossattributabletoownersofparent": 5400000000,
    "weightedaverageshares": 1251700000,
    "adjustedweightedaverageshares": 1256400000,
    "basicearningslosspershareattributabletoownersofparent": 4.31,
    "dilutedearningslosspershareattributabletoownersofparent": 4.3,
    "actuarialgainslossesarisingfromchangesinfinancialassumptionsnetdefinedbenefitliabilityasset": 171000000,
    "gainslossesrecognisedinothercomprehensiveincomefairvaluemeasuremententitysownequityinstruments": 97000000,
    "incometaxrelatingtocomponentsofothercomprehensiveincomethatwillnotbereclassifiedtoprofitorloss": 3000000,
    "othercomprehensiveincomethatwillnotbereclassifiedtoprofitorlossnetoftax": -77000000,
    "gainslossesonremeasuringdebtinstrumentsbeforetax": 21000000,
    "gainslossesoncashflowhedgesbeforetax": -1000000,
    "gainslossesonexchangedifferencesontranslationbeforetax": -1540000000,
    "incometaxrelatingtocomponentsofothercomprehensiveincomethatwillbereclassifiedtoprofitorloss": 6000000,
    "othercomprehensiveincomethatwillbereclassifiedtoprofitorlossnetoftax": -1526000000,
    "othercomprehensiveincome": -1603000000,
    "comprehensiveincome": 3833000000,
    "comprehensiveincomeattributabletoownersofparent": 3810000000,
    "comprehensiveincomeattributabletononcontrollinginterests": 23000000,
    "dividendsrecognisedasdistributionstoownersofparent": 4454000000,
    "dividendsrecognisedasdistributionstononcontrollinginterests": 59000000,
    "purchaseoftreasuryshares": 593000000,
    "increasedecreasethroughexerciseofoptions": 1000000,
    "increasedecreasethroughsharebasedpaymentplansissuanceofrestrictedsharesandvestingofexistingrestrictedshares": 3000000,
    "increasedecreasethroughsharebasedpaymentplansemployeeshareownershipplans": 4000000,
    "increasedecreasethroughsharebasedpaymentplansvalueofservicesobtainedfromemployees": 283000000,
    "increasedecreasethroughsharebasedpaymentplanstaxeffectsoftheexerciseofstockoptions": 3000000,
    "increasedecreasethroughissuanceofrestrictedsharesequity": 2000000,
    "increasedecreasethroughchangesinnoncontrollinginterestsarisingfromdivestment": 9000000,
    "dividendspaidordinarysharespershare": 3.56,
    "profitlossattributabletoordinaryequityholdersofparententity": 5400000000,
    "adjustmentsforundistributedprofitsofinvestmentsaccountedforusingequitymethod": -295000000,
    "adjustmentsfordepreciationandamortisationexpenseandimpairmentlossreversalofimpairmentlossofpropertyplantandequipmentrightofuseassetsandintangibleasset": 4792000000,
    "adjustmentsforlossesgainsondisposalofnoncurrentassets": -509000000,
    "adjustmentsfordeferredtaxexpense": -970000000,
    "adjustmentsfornoncurrentprovisionsandothernoncurrentliabilities": -136000000,
    "adjustmentsforsharebasedpayments": 283000000,
    "impactoftheworkdownofacquiredinventoriesremeasuredatfairvalue": 20000000,
    "otheradjustmentstoreconcileprofitloss": 283000000,
    "cashflowsfromusedinoperationsbeforechangesinworkingcapital": 9494000000,
    "adjustmentsfordecreaseincreaseininventories": -840000000,
    "adjustmentsfordecreaseincreaseintradeaccountreceivable": -397000000,
    "adjustmentsforincreasedecreaseintradeaccountpayable": 402000000,
    "netchangeinothercurrentassetsandothercurrentliabilities": 1599000000,
    "cashflowsfromusedinoperatingactivities": 10258000000,
    "purchaseofpropertyplantandequipmentintangibleassetsotherthangoodwillinvestmentpropertyandothernoncurrentassets": 3024000000,
    "cashflowsusedinobtainingcontrolofsubsidiariesorotherbusinessesclassifiedasinvestingactivities": 3870000000,
    "purchaseoffinancialinstrumentsclassifiedasinvestingactivities": 134000000,
    "proceedsfromdisposalsofpropertyplantandequipmentintangibleassetsotherthangoodwillinvestmentpropertyandothernoncurrentassets": 1015000000,
    "cashflowsfromlosingcontrolofsubsidiariesorotherbusinessesclassifiedasinvestingactivities": 42000000,
    "netchangeinothernoncurrentassets": -229000000,
    "cashflowsfromusedininvestingactivities": -6200000000,
    "proceedsfromissuingshares": 195000000,
    "dividendspaidtoequityholdersofparentclassifiedasfinancingactivities": 4454000000,
    "dividendspaidtononcontrollinginterestsclassifiedasfinancingactivities": 61000000,
    "paymentsfromchangesinownershipinterestsinsubsidiaries": 3000000,
    "proceedsfromnoncurrentborrowings": 48000000,
    "repaymentsofnoncurrentborrowings": 3684000000,
    "paymentsofleaseliabilitiesclassifiedasfinancingactivities": 265000000,
    "cashflowsfromusedinincreasedecreaseincurrentborrowingsandotherfinancialinstruments": 765000000,
    "paymentstoacquireorredeementitysshares": 593000000,
    "cashflowsfromusedinfinancingactivities": -8052000000,
    "effectofexchangeratechangesoncashandcashequivalents": -32000000,
    "increasedecreaseincashandcashequivalents": -4026000000,
    "incometaxespaidrefundclassifiedasoperatingactivities": 2623000000,
    "interestpaidclassifiedasoperatingactivities": 559000000,
    "interestreceivedclassifiedasoperatingactivities": 547000000,
    "dividendsreceivedfromnonconsolidatedentitiesclassifiedasoperatingactivities": 17000000,
    "disclosureofprincipalalliancestextblock": "Principal alliances",
    "disclosureofimpactofchangesinthescopeofconsolidationduetoacquisitionsanddivestmentsexplanatorytextblock": "Presentation of the financial statements",
    "disclosureofimpairmentofintangibleassetsandpropertyplantandequipmentexplanatorytextblock": "Impairment of intangible assets and property, plant and equipment",
    "disclosureoftradereceivablestextblock": "Accounts receivable",
    "disclosureoffinancialassetsandliabilitiesatfairvalueexplanatorytextblock": "Financial assets and liabilities measured at fair value",
    "disclosureofdebtinstrumentsissuedexplanatorytextblock": "Debt, cash and cash equivalents and lease liabilities",
    "disclosureofliabilitiesrelatedtobusinesscombinationsandtononcontrollinginterestsexplanatorytextblock": "Liabilities related to business combinations and to non-controlling interests",
    "disclosureofprovisionsandotherliabilitiestextblock": "Provisions, income tax liabilities and other liabilities",
    "disclosureofoffbalancesheetcommitmentsexplanatorytextblock": "Off balance sheet commitments",
    "disclosureoflegalandarbitralproceedingstextblock": "Legal and arbitral proceedings",
    "disclosureofprovisionsfordiscountsrebatesandsalesreturnstextblock": "Provisions for discounts, rebates and sales returns",
    "disclosureofrestructuringcostsandsimilaritemstextblock": "Restructuring costs and similar items",
    "disclosureofothergainsandlossesandlitigationtextblock": "Other gains and losses, and litigation",
    "disclosureofshareofprofitlossofassociatesandjointventuresaccountedforusingequitymethodtextblock": "Share of profit/loss from investments accounted for using the equity method",
    "disclosureofprofitlossattributabletononcontrollingintereststextblock": "Net income attributable to non-controlling interests",
    "agreementsrelatingtotherecombinantcovid19vaccinecandidatedevelopedbysanofiincollaborationwithgskpolicytextblock": "Agreements relating to the recombinant COVID-19 vaccine candidate developed by Sanofi in collaboration with GSK",
    "descriptionofaccountingpolicyforbasisofconsolidationpolicytextblock": "Basis of consolidation",
    "descriptionofaccountingpolicyforcostofsalesexplanatory": "Cost of sales",
    "descriptionofaccountingpolicyforotheroperatingincomeandexpensesexplanatorypolicytextblock": "Other operating income and expenses",
    "descriptionofaccountingpolicyforfairvalueremeasurementofcontingentconsiderationliabilitiesexplanatorypolicytextblock": "Fair value remeasurement of contingent consideration",
    "descriptionofaccountingpolicyforrestructuringcostsandsimilaritemspolicytextblock": "Restructuring costs and similar items",
    "descriptionofaccountingpolicyforothergainsandlossesandlitigationexplanatorypolicytextblock": "Other gains and losses, and litigation",
    "disclosureofestimatedusefullivesofpropertyplantandequipmentexplanatorytabletextblock": "The customary useful lives of property, plant and equipment are as follows:Buildings15 to 40 yearsFixtures10 to 20 yearsMachinery and equipment5 to 15 yearsOther3 to 15 years",
    "disclosureofoffbalancesheetcommitmentsofpropertyplantandequipmenttabletextblock": "Off balance sheet commitments relating to property, plant and equipment as of December 31, 2023, 2022 and 2021 are set forth below:(€ million)202320222021Firm orders of property, plant and equipment638 861 769 Property, plant and equipment pledged as security for liabilities16 — 9",
    "disclosureofimpairmentlossesofpropertyplantandequipmenttabletextblock": "The table below sets forth the net impairment losses recognized in each of the last three financial periods:(€ million)202320222021Net impairment losses on property, plant and equipment(a)130 186 39 (a)    These amounts mainly comprise impairment losses recognized as a result of decisions taken during the periods presented, relating primarily to shutdowns or changes in use of industrial sites.",
    "disclosureofgoodwillbyoperatingsegmentsexplanatorytabletextblock": "The allocation of goodwill by segment as of December 31, 2023 is as follows:(€ million)BiopharmaConsumer HealthcareTotalGoodwill42,324 7,080 49,404",
    "disclosureofamortizationofsoftwareandotherrightsbyincomestatementlinetabletextblock": "An analysis of amortization of software is shown in the table below:",
    "disclosureofassetsheldforsaleorexchangeandrelatedliabilitiestabletextblock": "Assets held for sale or exchange, and liabilities related to assets held for sale or exchange, comprise:(€ million)December 31, 2023December 31, 2022December 31, 2021Assets held for sale or exchange15 85 89 Liabilities related to assets held for sale or exchange13 10 —",
    "disclosureofdetailedinformationaboutinventoriestabletextblock": "Inventories comprise the following:202320222021(€ million)GrossvalueAllowancesCarryingamountGrossvalueAllowancesCarryingamountGrossvalueAllowancesCarryingamountRaw materials1,676 (126)1,550 1,613 (139)1,474 1,344 (66)1,278 Work in process5,869 (553)5,316 5,663 (678)4,985 5,579 (554)5,025 Finished goods3,045 (245)2,800 2,748 (247)2,501 2,696 (284)2,412 Total10,590 (924)9,666 10,024 (1,064)8,960 9,619 (904)8,715",
    "disclosureofcurrenttradereceivablestabletextblock": "Accounts receivable break down as follows:(€ million)December 31, 2023December 31, 2022December 31, 2021Gross value8,528 8,537 7,705 Allowances(95)(113)(137)Carrying amount8,433 8,424 7,568",
    "disclosureofoverduereceivablesgrossvaluetabletextblock": "Overdue accountsOverdue byOverdue byOverdue byOverdue byOverdue by(€ million)gross value<1 month1 to 3 months3 to 6 months6 to 12 months> 12 monthsDecember 31, 2023689 269 154 123 62 81 December 31, 2022452 118 161 87 35 51 December 31, 2021455 169 151 67 12 56",
    "disclosureofsharerepurchaseprogramexplanatorytabletextblock": "The following repurchases have been made under those programs:",
    "disclosureofreserveofexchangedifferencesontranslationtabletextblock": "Currency translation differences comprise the following:(€ million)202320222021Attributable to equity holders of Sanofi(31)1,499 (865)Attributable to non-controlling interests(37)(37)(42)Total(68)1,462 (907)",
    "disclosureofsharesusedtocomputedilutedearningspersharetabletextblock": "(million)202320222021Average number of shares outstanding1,251.7 1,251.9 1,252.5 Adjustment for stock options with dilutive effect0.2 0.3 0.3 Adjustment for restricted shares4.5 4.7 5.1 Average number of shares used to compute diluted earnings per share1,256.4 1,256.9 1,257.9",
    "disclosureofdebtbyinterestrateatvalueofredemptionaftertakingaccountofderivativeinstrumentsn1n2tabletextblock": "The table below shows the fixed/floating rate split of net debt at value on redemption after taking account of derivative instruments as of December 31, 2022 and December 31, 2021:(€ million)2022%2021%Fixed-rate debt16,386 85 %17,612 87 %Floating-rate debt2,886 15 %2,702 13 %Debt19,273 100 %20,314 100 %Cash and cash equivalents(12,781)(10,267)Net debt6,492 10,047",
    "disclosureofsensitivityanalysisonlongtermborrowingsanddebtsecuritiesassuminga1increaseanddecreaseininterestratestabletextblock": "The projected full-year sensitivity of net debt to interest rate fluctuations for 2024 is as follows:Change in short-term interest ratesImpact on pre-tax netincome (€ million)Impact on pre-taxincome/(expense) recognizeddirectly in equity(€ million)+100 bp48 — +25 bp12 — -25 bp(12)— -100 bp(48)—",
    "disclosureofdebtbycurrencyatvalueofredemptionbeforeandafterderivativeinstrumentstabletextblock": "The table below shows net debt by currency at December 31, 2023, before and after derivative instruments contracted to convert the foreign-currency net debt of exposed entities into their functional currency:(€ million)Before derivative instrumentsAfter derivative instrumentsEuro10,113 6,852 US dollar(2,376)1,169 Singapore dollar(3)(1,143)Pound sterling— 509 Chinese yuan renminbi(19)189 Other currencies166 259 Net debt7,881 7,835",
    "disclosureofdebtbycurrencyatvalueofredemptionafterderivativeinstrumentstabletextblock": "The table below shows net debt by currency at December 31, 2022 and 2021, after derivative instruments contracted to convert the foreign currency net debt of exposed entities into their functional currency:(€ million)20222021Euro10,489 13,129 US dollar(2,404)(669)Other currencies(1,593)(2,413)Net debt6,492 10,047",
    "disclosureofmarketvalueofnetdebttabletextblock": "The market value of Sanofi’s debt, net of cash and cash equivalents and derivatives and excluding accrued interest, is as follows:(€ million)202320222021Market value7,086 5,227 11,024 Value on redemption7,835 6,492 10,047",
    "disclosureofmaximumamountofcontingentconsiderationpayableandfirmcommitmentstobuyoutnoncontrollinginterestsexplanatorytabletextblock": "The table below sets forth the maximum amount of contingent consideration payable in respect of already-marketed products:December 31, 2023TotalPayments due by period(€ million)Less than1 yearFrom 1 to3 yearsFrom 3 to5 yearsMore than5 yearsCommitments relating to contingent consideration in connection with business combinations133 69 64 — —",
    "disclosureofweightedaveragedurationofdefinedbenefitobligationtabletextblock": "The table below shows the duration of Sanofi’s obligations in the principal countries:202320222021(years)FranceGermanyUSUKFranceGermanyUSUKFranceGermanyUSUKWeighted average duration101211131012111312161517",
    "disclosureofpretaxactuariallossexplanatorytabletextblock": "The net pre-tax actuarial loss (excluding investments accounted for using the equity method) recognized directly in equity is presented below:(€ million)202320222021Net pre-tax actuarial loss(2,259)(2,090)(2,738)",
    "disclosureofpensionandotherpostemploymentbenefitexpensetabletextblock": "The present value of Sanofi’s obligations in respect of pension and other post-employment benefit plans at the end of each reporting period is shown below:(€ million)202320222021Present value of wholly or partially funded obligations in respect of pension and other post-employment benefit plans7,693 7,463 10,416 Present value of unfunded obligations1,237 1,188 1,759 Total8,930 8,651 12,175",
    "disclosureofexpenseforpensionsandotherpostemploymentbenefitsbyincomestatementlineexplanatorytabletextblock": "The total expense for pensions and other post-employment benefits (€190 million in 2023) is allocated between income statement line items as follows:(€ million)202320222021Cost of sales34 55 77 Research and development expenses28 52 65 Selling and general expenses61 81 87 Other operating (income)/expenses, net5 (2)(1)Restructuring costs(9)(61)6 Financial expenses71 43 42 Total190 168 276",
    "disclosureofestimatedamountsofemployerscontributionstoplanassetstabletextblock": "The estimated amounts of employer’s contributions to plan assets in 2024 are as follows:(€ million)FranceGermanyUSUKOtherTotalEmployer’s contributions in 2024 (estimate):2024— — — 46 40 86",
    "disclosureofexpectedtimingofpaymentsunderpensionandotherpostemploymentbenefitplanstabletextblock": "The table below shows the expected timing of benefit payments under pension and other post-employment benefit plans for future years:(€ million)FranceGermanyUSUKOtherTotalEstimated future benefit payments2024103 198 102 116 60 579 202568 212 91 120 54 545 202660 218 95 123 60 556 202779 221 98 127 59 584 202893 229 101 131 62 616 2029 to 2033438 1,190 526 716 343 3,213",
    "disclosureofexpectedtimingofpaymentsinrespectofunfundedpensionandotherpostemploymentbenefitplansexplanatorytabletextblock": "The table below shows estimates as of December 31, 2023 for the timing of future payments in respect of unfunded pension and other post-employment benefit plans:TotalPayments due by period(€ million)Less than 1 year1 to 3 years3 to 5 yearsMore than5 yearsEstimated payments1,238 86 117 144 891",
    "disclosureofotherlongtermprovisionstabletextblock": "Other provisions include provisions for risks and litigation relating to environmental, tax, commercial and product liability matters.(€ million)202320222021Environmental risks493 526 650 Product liability risks, litigation and other1,283 1,652 1,374 Total1,776 2,178 2,024",
    "disclosureofundrawnborrowingfacilitiestabletextblock": "Undrawn credit facilities are as follows:December 31, 2023TotalExpiry(€ million)Less than1 year1 to3 years3 to5 yearsMore than5 yearsGeneral-purpose credit facilities8,000 — — 4,000 4,000",
    "disclosureofguaranteesgivenandreceivedexplanatorytabletextblock": "The table below shows the amount of guarantees given and received:(€ million)202320222021Guarantees given:3,936 3,815 3,794 •Guarantees provided to banks in connection with credit facilities1,067 1,007 1,042 •Other guarantees given2,869 2,808 2,752 Guarantees received(1,272)(1,229)(1,149)",
    "disclosureofpersonnelcostsdetailstabletextblock": "Total personnel costs (other than termination benefits, presented in Note D.27.) include the following items:(€ million)202320222021Salaries7,183 7,145 6,625 Social security charges (including defined-contribution pension plans)2,100 2,098 1,929 Other employee benefits(a) 531 748 786 Total9,814 9,991 9,340 (a) Includes expenses related to share-based payments and defined-benefit plans.",
    "disclosureofallocationofincometaxbetweencurrentanddeferredtaxestabletextblock": "The table below shows the allocation of income tax expense between current and deferred taxes:(€ million)202320222021Current taxes(2,560)(2,774)(1,908)Deferred taxes958 768 350 Total(1,602)(2,006)(1,558)Income before tax and investments accounted for using the equity method7,153 10,422 7,798",
    "disclosureofinformationabouttheamountsattributabletononcontrollinginterestsexplanatorytabletextblock": "The table below shows Net income attributable to non-controlling interests for the reporting periods presented:(€ million)202320222021Share of net income attributable to non-controlling interests36 113 56 Total36 113 56",
    "disclosureofcompensationpaidtokeymanagementpersonneltabletextblock": "The table below shows, by type, the compensation paid to key management personnel:(€ million)202320222021Short-term benefits(a)36 31 33 Post-employment benefits2 2 2 Share-based payment8 19 20 Total recognized in profit or loss46 52 55 (a) Compensation, employer’s social security contributions, directors’ compensation, and any termination benefits (net of reversals of termination benefit obligations).",
    "auditorsremunerationtabletextblock": "The table below shows fees charged by those firms and member firms of their networks to Sanofi and consolidated subsidiaries in the years ended December 31, 2023 and 2022.",
    "disclosureofinvestmentsinsubsidiariesexplanatorytabletextblock": "Financial interest (%) as of December 31, 2023Haleon US, LPUnited States11.7 Infraserv GmbH & Co. Höchst KGGermany31.2 MapharMorocco48.3 MCM Vaccine BVNetherlands50.0 MSP Vaccine Company (formerly MCM company)United States50.0 EUROAPIFrance29.8",
    "averageeffectivetaxrate": 0.15,
    "increasedecreaseineffectivetaxrate": 0.015,
    "planetcareprogramobjectivespercentageofreductioninscope1and2greenhousegasby2030": 0.55,
    "planetcareprogramobjectivespercentageofreductioninscope3greenhousegasby2030": 0.3,
    "planetcareprogramobjectivespercentageofreductioninallscopesgreenhousegasby2030": 0.9,
    "planetcareprogramobjectivespercentageofrenewablysourcedenergyinallsitesby2030": 1,
    "planetcareprogramobjectivesnumberofglobalwarmingscenarios": 3,
    "cumulativeconsumerpriceinflationoverthelastthreeyears": 1,
    "governmentgrantrecognisedasdeductionfromdevelopmentexpenses": 59000000,
    "otherrevenueperformanceobligationnolongerrequired": 94000000,
    "usefullifemeasuredasperiodoftimeintangibleassetsotherthangoodwill": "P3Y",
    "usefullifemeasuredasperiodoftimepropertyplantandequipment": "P15Y",
    "deferredtaxexpenseincome": -958000000,
    "optionvestingperiod": "P4Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod": "P3Y",
    "numberofoperatingsegments1": 2,
    "percentageofsecondpartofdevelopmentcostsfunded": 0.8,
    "percentageofsecondpartofdevelopmentcostsfundedbyotherparty": 0.2,
    "percentageofprofitshareoncounterpartiesprofit": 0.2,
    "percentageofcumulativedevelopmentcostsreimbursed": 0.5,
    "periodbeforelaunchdateduringwhichcommercialexpensesofantibodiescodevelopedunderlicenseagreementareshared": "P24M",
    "percentageofprofitsandlossesarisingfromcommercialoperations": 0.5,
    "percentageofprofitsarisingfromcommercialoperations": 0.55,
    "percentageoflossesarisingfromcommercialoperations": 0.55,
    "paymentrelatedtoattainmentofgoal": 50000000,
    "otheroperatingincomeexpense": 116000000,
    "proceedsfromcollaborationagreements": 196000000,
    "commitmentsrelatedtomilestonepaymentsforprojectsundercollaborationagreement": 375000000,
    "accruals": 25000000,
    "percentageofnetsalesarisingfromcommercialoperations": 0.25,
    "percentageofdevelopmentcostsarisingfromcommercialoperations": 0.5,
    "additionsotherthanthroughbusinesscombinationsintangibleassetsotherthangoodwill": 1062000000,
    "othernoncurrentliabilities": 2340000000,
    "goodwilltaxdeductibleperiod": "P15Y",
    "proportionofownershipinterestinassociate": 0.298,
    "proportionofownershipinterestinsubsidiary": 1,
    "changeinscopeofconsolidationthroughbusinesscombinationspropertyplantandequipment": -11000000,
    "depreciationexpense": 321000000,
    "writedownsreversalsofpropertyplantandequipment": 30000000,
    "additionsotherthanthroughbusinesscombinationspropertyplantandequipment": 27000000,
    "disposalsandretirementspropertyplantandequipment": 2000000,
    "increasedecreasethroughnetexchangedifferencespropertyplantandequipment": -5000000,
    "increasedecreasethroughtransferspropertyplantandequipment": -2000000,
    "interestcostscapitalised": 26000000,
    "firmordersofpropertyplantandequipment": 638000000,
    "propertyplantandequipmentpledgedassecurity": 16000000,
    "impairmentlossrecognisedinprofitorlosspropertyplantandequipment": 130000000,
    "additionsotherthanthroughbusinesscombinationspropertyplantandequipmentrightofuseassets": 247000000,
    "depreciationrightofuseassets": 292000000,
    "disposalsandretirementspropertyplantandequipmentrightofuseassets": 314000000,
    "increasedecreasethroughnetexchangedifferencespropertyplantandequipmentrightofuseassets": -58000000,
    "increasedecreasethroughtransferspropertyplantandequipmentrightofuseassets": -75000000,
    "initialleaseterm": "P15Y",
    "leaseliabilities": 2030000000,
    "leasedassetspercentage": 0.9,
    "expenserelatingtoshorttermleasesandlowvalueassetsforwhichrecognitionexemptionhasbeenused": 19000000,
    "cashoutflowforleases": 315000000,
    "intangibleassetsandgoodwill": 49404000000,
    "acquisitionsthroughbusinesscombinationsintangibleassetsandgoodwill": 475000000,
    "increasedecreasethroughotherchangesintangibleassetsandgoodwill": -90000000,
    "increasedecreasethroughnetexchangedifferencesintangibleassetsandgoodwill": -873000000,
    "otherintangibleassets": 9772000000,
    "changeinscopeofconsolidationthroughbusinesscombinationintangibleassets": 113000000,
    "impairmentlossrecognisedinothercomprehensiveincomeintangibleassetsotherthangoodwill": 90000000,
    "disposalsandretirementsintangibleassetsotherthangoodwill": 262000000,
    "increasedecreasethroughnetexchangedifferencesintangibleassetsotherthangoodwill": -242000000,
    "increasedecreasethroughtransfersintangibleassetsotherthangoodwill": -1253000000,
    "concentrationriskthresholdpercentage": 0.96,
    "remainingamortisationperiodofintangibleassetsmaterialtoentity2019": "P2Y",
    "impairmenttestingpercentage": 0.07,
    "uniformimpairmenttestingpercentage": 0.072,
    "pretaxdiscountrateappliedforgoodwill": 0.093,
    "uniformpretaxdiscountrates": 0.099,
    "descriptionofgrowthrateusedtoextrapolatecashflowprojections": 0.01,
    "percentageofdiscountrateaboverateactuallyusedwouldnotcauseimpairmentloss": 2.8,
    "percentageofperpetuitygrowthratebelowtheratesactuallyusedwouldnotcauseimpairmentloss": 4.9,
    "percentageofoperatingmarginratebelowratesactuallyusedwouldnotcauseimpairmentloss": 7.2,
    "aftertaxdiscountrates": 0.0725,
    "impairmentlossonintangibleassetsotherthangoodwill": 932000000,
    "proportionofownershipinterestinjointventure": 0.312,
    "investmentsinjointventures": 162000000,
    "investmentsinsubsidiariesjointventuresandassociates": 424000000,
    "impairmentlossrecognisedinprofitorloss": 231000000,
    "stockprice": 5.73,
    "shareofprofitlossofjointventuresaccountedforusingequitymethod": 101000000,
    "shareofothercomprehensiveincomeofassociatesandjointventuresaccountedforusingequitymethodbeforetax": -7000000,
    "totalshareofprofitandcomprehensiveincomeofassociatesandjointventures": 94000000,
    "revenuefromsaleofgoodsrelatedpartytransactions": 157000000,
    "royaltiesandotherincomerelatedpartytransactions": 63000000,
    "amountsreceivablerelatedpartytransactions": 249000000,
    "purchasesofgoodsrelatedpartytransactions": 642000000,
    "amountspayablerelatedpartytransactions": 71000000,
    "noncurrentfinancialassetsatfairvaluethroughothercomprehensiveincome": 1088000000,
    "noncurrentfinancialassetsatfairvaluethroughprofitorloss": 808000000,
    "prefundedpensionobligations": 271000000,
    "longtermprepaidexpenses": 114000000,
    "noncurrentloansandreceivables": 591000000,
    "noncurrentfinanceleasereceivables": 132000000,
    "noncurrentfinanceleasereceivablesgross": 170000000,
    "equityinstrumentsatfairvaluethroughothercomprehensiveincomeloss10declineincreditpricespretaxamount": 47000000,
    "fairvalueofinvestmentsinequityinstrumentsdesignatedasmeasuredatfairvaluethroughothercomprehensiveincome": 618000000,
    "financialassetsatfairvaluethroughothercomprehensiveincome": 346000000,
    "noncurrentassetsotherthanfinancialinstrumentsdeferredtaxassetspostemploymentbenefitassetsandrightsarisingunderinsurancecontracts": 107000000,
    "othercomprehensiveincomebeforetax": 1000000,
    "unrealizedgainslossesonsecuritiesmeasuredatfairvaluethroughothercomprehensiveincomethatwillbereclassifiedtoprofitandlossrecognizedinequity": 349000000,
    "fairvalueofthecontingentconsideration": 214000000,
    "financialinvestments": 572000000,
    "financialassetsatfairvaluethroughprofitorloss": 132000000,
    "rawmaterials": 1676000000,
    "workinprogress": 5869000000,
    "finishedgoods": 3045000000,
    "impairmentlossrecognisedinprofitorlosstradereceivables": 8000000,
    "overduereceivablesgrossvalue": 689000000,
    "derecognizedreceivables": 761000000,
    "currentreceivablesfromtaxesotherthanincometax": 768000000,
    "currentprepaidexpenses": 768000000,
    "othercurrentreceivables": 1448000000,
    "currencyderivativesmeasuredatfairvalue": 201000000,
    "othercurrentfinancialassets": 270000000,
    "financialassets": 470000000,
    "financialliabilities": 127000000,
    "cash": 1461000000,
    "cashequivalents": 7249000000,
    "cashequivalentsmoneymarketmutualfunds": 5349000000,
    "shorttermdepositsclassifiedascashequivalents": 1191000000,
    "cashequivalentscaptiveinsuranceandreinsurancecompanies": 476000000,
    "deferredtaxliabilityasset": -1525000000,
    "reserveslikelytobedistributedintheforeseeablefuture": 60400000000,
    "temporarydifferencesassociatedwithinvestmentsinsubsidiariesbranchesandassociatesandinterestsinjointventures": 10000000000,
    "totaldeferredtaxassetsfortaxlosscarryforwards": 2729000000,
    "unusedtaxlossesforwhichnodeferredtaxassetrecognised": 1203000000,
    "unusedcapitallossesforwhichnodeferredtaxassetrecognised": 473000000,
    "deferredtaxassetsnotrecognizedasfuturerecoverynotprobable": 1062000000,
    "taxlossescarryforwards": 6000000,
    "taxlosscarryforwardsonassetdisposals": 5000000,
    "issuedcapital": 2529599938,
    "numberofsharesissued": 1264799969,
    "parvaluepershare": 2,
    "periodofsharerepurchaseprogram": "P18M",
    "hedgesofnetinvestmentsinforeignoperationsaftertax": 574000000,
    "shareholdersequityincreaseduetotheexerciseofallstocksubscriptionoptions": 107000000,
    "numberofsharesissuedbyexerciceofeachoption": 1,
    "numberofsharesheld": 13450000,
    "percentageofsharecapitalfortheperiod": 0.01063,
    "numberofsharesissuedinregardsofcapitalincreasebyexerciseofstocksubscriptionoptions": 504956,
    "numberofrestrictedsharesissuedinregardsofcapitalincrease": 1330558,
    "numberofyearsserviceperiod": "P3Y",
    "numberofshareoptionsgrantedinsharebasedpaymentarrangement": 3838434,
    "fairvaluepershareawardedforthreeyearserviceperiod": 87.69,
    "fairvaluepershareawardedforthreeyearserviceperiodadditionalshares": 43.6,
    "fairvaluepershareawardedforthreeyearserviceperiodtochiefexecutiveofficer": 82.17,
    "fairvalueofplanatdateofgrant": 326000000,
    "expensefromequitysettledsharebasedpaymenttransactionsinwhichgoodsorservicesreceiveddidnotqualifyforrecognitionasassets": 231000000,
    "numberofrestrictedsharesnotyetfullyvested": 9773084,
    "percentageofaverageofquotedmarketpricesofshares": 0.8,
    "numberoftradingdaysprecedingplanapproval": "P20D",
    "expensefromequitysettledsharebasedpaymenttransactionsofwhichgoodsorservicesreceiveddidnotqualifyforrecognitionasassetsemployercontribution": 12000000,
    "numberofsharesrepurchased": 2584540,
    "amountofsharesrepurchased": 230000000,
    "actuarialgainslossesarisingfromchangesinfinancialassumptionsnetdefinedbenefitliabilityassetexcludingassociatesandjointventures": -171000000,
    "incometaxrelatingtoactuarialgainslossesarisingfromchangesinfinancialassumptionsnetdefinedbenefitliabilityassetnetoftaxonassociatesandjointventures": -18000000,
    "changeinfairvalueonequityinstrumentsexcludingassociatesandjointventures": 97000000,
    "incometaxrelatingtochangeinfairvalueofequityinstrumentsexcludingequitymethod": 21000000,
    "changeinfairvalueondebtinstrumentexcludingassociatesandjointventures": 21000000,
    "incometaxrelatingtochangeinfairvalueofdebtinstrumentexcludingassociatesandjointventures": 4000000,
    "changeinfairvalueoncashflowhedgesexcludingassociatesandjointventures": 1000000,
    "changeinfairvalueoncashflowhedgesnetoftaxonassociatesandjointventures": -2000000,
    "changeincurrencytranslationbeforetaxexcludingassociatesandjointventures": -1551000000,
    "changeincurrencytranslationnetoftaxonassociatesandjointventures": 3000000,
    "changeincurrencytranslationonhedgesofnetinvestmentsinforeignoperations": 8000000,
    "changeincurrencytranslationontaxeffects": 2000000,
    "stockbasedcompensationstockoptionsexercisedpricepershare": 72.19,
    "numberofoutstandingshareoptions": 91355,
    "numberofshareoutstandinginsharebasedpaymentarrangement": 1333013,
    "numberofshareoptionsexercisableinsharebasedpaymentarrangement": 1333013,
    "numberofshareoptionsexercisedinsharebasedpaymentarrangement": 504956,
    "weightedaverageexercisepriceofshareoptionsoutstandinginsharebasedpaymentarrangement2019": 80.53,
    "weightedaverageexercisepriceofshareoptionsexercisableinsharebasedpaymentarrangement2019": 80.53,
    "weightedaverageexercisepriceofshareoptionsexercisedinsharebasedpaymentarrangement2019": 73.65,
    "valueofshareoptionsoutstandinginsharebasedpaymentarrangement": 107000000,
    "valueofshareoptionsexercisableinsharebasedpaymentarrangement": 107000000,
    "valueofshareoptionsexercisedinsharebasedpaymentarrangement": 37000000,
    "exercisepriceofoutstandingshareoptions2019": 60,
    "weightedaverageremainingcontractuallifeofoutstandingshareoptions2019": "P4Y4M2D",
    "dilutiveeffectofshareoptionsonnumberofordinaryshares": 200000,
    "dilutiveeffectofshareoptionsonnumberofrestrictedshares": 4500000,
    "interestrateandcurrencyderivativesusedtomanagedebt": -139000000,
    "borrowings": 16531000000,
    "interestrateandcurrencyderivativesusedtomanagecashandcashequivalent": 28000000,
    "debtnetofcashandcashequivalents": 7793000000,
    "repaymentsofborrowingsclassifiedasfinancingactivities": 12000000,
    "proceedsfromborrowingsclassifiedasfinancingactivities": 48000000,
    "otherinflowsoutflowsofcashclassifiedasfinancingactivities": 903000000,
    "foreigncurrencytranslationdifferences": -30000000,
    "reclassificationfromnoncurrenttocurrent": -604000000,
    "otheradjustmentsfornoncashitems": 88000000,
    "numberofbondissuesredeemed": 3,
    "notionalamount": 4000000000,
    "creditfacilitiesextensionoptionperiod": "P1Y",
    "numberofcreditfacilities": 2,
    "numberofsustainabledevelopmentperformanceindicators": 2,
    "participatingsharesnumberoutstanding": 58115,
    "participatingsharescarryingamount": 9000000,
    "numberofcommercialpaperprograms": 2,
    "commercialpapersissued": 6000000000,
    "borrowingaveragedrawdown": 200000000,
    "borrowingmaximumdrawdown": 800000000,
    "borrowingdrawdown": 40000000,
    "numberofcurrenciesdebtisissuedin": 2,
    "borrowingsinterestrate": 0.016,
    "cashandcashequivalentsinvestedrate": 0.039,
    "bondsissued": 14416000000,
    "otherbankborrowings": 130000000,
    "otherborrowings": 6000000,
    "bankoverdraftsclassifiedascashequivalents": 203000000,
    "increasedecreaseofborrowings": 16080000000,
    "debtpercent": 0.97,
    "impactofchangeininterestrateonpretaxincome": 48000000,
    "redemptionofdebtinstrumentissued": 7835000000,
    "nonderivativefinancialliabilitiesundiscountedcashflows": 17710000000,
    "principalundiscountedcashflow": 16468000000,
    "interestundiscountedcashflow": 1242000000,
    "derivativefinancialliabilitiesundiscountedcashflows": 143000000,
    "totalundiscountedcashflow": 17853000000,
    "leaseliabilitieseffectofdiscounting": 58000000,
    "contingentliabilitiesrecognisedinbusinesscombination": 127000000,
    "settledliabilitiescontingentliabilitiesrecognisedinbusinesscombination": 21000000,
    "gainslossesrecognisedinprofitorlossfairvaluemeasurementliabilities": 5000000,
    "increasedecreasethroughnetexchangedifferencesbusinesscombinationsandnoncontrollinginterests": -13000000,
    "percentageincreaseinfairvalueliabilities": 0.01,
    "commitmentsrelatingtocontingentconsiderationinconnectionwithbusinesscombinations": 133000000,
    "noncurrentprovisions": 5262000000,
    "noncurrentderivativefinancialliabilities": 164000000,
    "changesinotherprovisions": 141000000,
    "provisionusedotherprovisions": 162000000,
    "increasedecreaseofunusedprovisionreversedotherprovisions": 21000000,
    "increasedecreasethroughtransfersandotherchangesotherprovisions": -1000000,
    "netinterestrelatedtoemployeesbenefitsandunwindingofdiscount": 70000000,
    "increasedecreasethroughnetexchangedifferencesotherprovisions": -23000000,
    "actuarialgainsandlossesondefinedbenefitplans": 171000000,
    "numberofcountriesincludedinpensionplans": 4,
    "pensionobligationpercentagetodefinedbenefitliability": 0.89,
    "pensionobligationpercentagetoplanassets": 0.88,
    "employercontributepercentageonamountsexceedingthesocialsecurityceiling": 0.14,
    "definedbenefitobligationatpresentvalue": 744000000,
    "numberofdefinedbenefitplans": 2,
    "liabilityassetofdefinedbenefitplans": 23000000,
    "definedbenefitplansvestingrightspercentage": 0.0125,
    "retirementage": 65,
    "notionalretirementage": 60,
    "averageresidualholdingperiodsundervariousearlyretirementplans": "P2Y2M19D",
    "identifiedenvironmentalrisksprovisionsestimatedobligationperiod": "P30Y",
    "identifiedenvironmentalrisksprovisionsexpectedutilizedamountnexttwelvemonths": 86000000,
    "identifiedenvironmentalrisksprovisionsexpectedutilizedamountyeartwotofive": 194000000,
    "inventorytotalquotasheld": 3000000,
    "taxchargeondeemedrepatriationattributabletoaccumulatedearningspayableperiod": "P8Y",
    "actuarialassumptionofdiscountrates": 0.0295,
    "actuarialassumptionofexpectedratesofinflation": 0.022,
    "actuarialassumptionofexpectedratesofpensionincreases": 0.022,
    "actuarialassumptionofmedicalcosttrendrates": 0.04,
    "actuarialassumptionofretirementage2019": "P62Y",
    "weightedaveragedurationofdefinedbenefitobligation2019": "P0Y",
    "percentageofreasonablypossibledecreaseinactuarialassumption": 0.005,
    "percentageofreasonablypossibleincreaseinactuarialassumption": 0.005,
    "increasedecreaseindefinedbenefitobligationduetoreasonablypossibleincreaseinactuarialassumption": 56000000,
    "possibleincreaseinmortalitytableinyears": "P1Y",
    "currentservicecostnetdefinedbenefitliabilityasset": 140000000,
    "interestexpenseincomenetdefinedbenefitliabilityasset": 346000000,
    "actuarialgainslossesarisingfromchangesindemographicassumptionsnetdefinedbenefitliabilityasset": 34000000,
    "actuarialgainslossesarisingfromexperienceadjustmentsnetdefinedbenefitliabilityasset": -256000000,
    "decreaseincreaseinnetdefinedbenefitliabilityassetresultingfromplanamendmentscurtailmentsorsettlementsnotspecifiedinthetermsoftheplan": 36000000,
    "decreaseincreaseinnetdefinedbenefitliabilityassetresultingfrompaymentsinrespectofsettlementsspecifiedinthetermsoftheplannetdefinedbenefitliabilityasset": 40000000,
    "benefitspaidorpayable": 483000000,
    "increasedecreasethroughbusinesscombinationsanddisposalsnetdefinedbenefitliabilityasset": -14000000,
    "increasedecreasethroughchangesinforeignexchangeratesnetdefinedbenefitliabilityasset": -13000000,
    "returnonplanassetsnetdefinedbenefitliabilityasset": 197000000,
    "decreaseincreaseinnetdefinedbenefitliabilityassetresultingfromadministrationcostsandtaxespaidduringtheperiod": -7000000,
    "contributionstoplanbyplanparticipantsnetdefinedbenefitliabilityasset": 6000000,
    "contributionstoplanbyemployernetdefinedbenefitliabilityasset": 122000000,
    "paymentsfromplannetdefinedbenefitliabilityasset": -446000000,
    "recognisedliabilitiesdefinedbenefitplan": 1937000000,
    "totalexpenseforpensionsandotherpostemploymentbenefitsrecognizeddirectlyinprofitorloss": 190000000,
    "gainlossonremeasurementofnetdefinedbenefitliabilityasset": 171000000,
    "employeebenefitsexpensegain": 361000000,
    "planassetsatfairvalue": 675000000,
    "planassetseffectofassetceiling": -6000000,
    "percentagecontributedtofairvalueofplanassetssecuritiesquotedinanactivemarket": 0.849,
    "percentagecontributedtofairvalueofplanassetsothersecurities": 0.151,
    "percentagecontributedtofairvalueofplanassets": 1,
    "gainslossesrelatedtoplanamendmentscurtailmentsorsettlement": 20000000,
    "interestexpenseincomeincludingadministrationcostsandtaxespaidnetdefinedbenefitliabilityasset": 22000000,
    "expensegainfortheperiodnetdefinedbenefitliabilityasset": 55000000,
    "decreaseincreaseinnetdefinedbenefitliabilityassetresultingfromactuarialgainslossesonexperienceadjustments": 16000000,
    "netpretaxactuariallossexcludingassociatesandjointventuresrecognizeddirectlyinequity": -2259000000,
    "restructuringcostsreversedandsimilaritems": -9000000,
    "totalexpenseforpensionandotherpostemploymentbenefitsrecognizeddirectlyinprofitorloss": 190000000,
    "estimateofcontributionsexpectedtobepaidtoplan": 46000000,
    "estimatedfuturebenefitpaymentsunderpensionandotherpostemploymentbenefitplans": 103000000,
    "expectedtimingofpaymentsinrespectofunfundedpensionandotherpostemploymentbenefitplans": 1238000000,
    "longtermrestructuringprovision": 554000000,
    "shorttermrestructuringprovision": 578000000,
    "changeinprovisionsrecognizedinprofitorlossfortheperiod": 435000000,
    "unwindingofdiscount": 31000000,
    "noncurrentprovisionforenvironmentrisks": 493000000,
    "noncurrentprovisionforproductliabilityriskslitigationandother": 1283000000,
    "otherlongtermprovisions": 1776000000,
    "currentpayablesonsocialsecurityandtaxesotherthanincometax": 395000000,
    "shorttermemployeebenefitsaccruals": 2106000000,
    "currentinterestratederivativespayable": 1000000,
    "currentcurrencyderivativespayable": 126000000,
    "amountspayableforacquisitionofnoncurrentassets": 945000000,
    "othercurrentliabilities": 9590000000,
    "royaltiespayable": 131000000,
    "currentderivativefinancialassets": 201000000,
    "derivativefinancialassets": 201000000,
    "currentderivativefinancialliabilities": 126000000,
    "derivativefinancialliabilities": 126000000,
    "financialinstrumentsdesignatedashedginginstrumentsatfairvalue": 75000000,
    "derivativefinancialinstruments": 6112000000,
    "derivativefinancialinstrumentstomanagefinancialexposure": 10279000000,
    "interestrateswapsinterestrate": 0.0103,
    "currencyandinterestratederivativesusedtomanagedebtnetofcashandcashequivalents": 453000000,
    "derivativefinancialassetsandliabilitiesgrosscarryingamountsbeforeoffset": 201000000,
    "netamountsasreportedinthebalancesheet": 201000000,
    "effectsofothernettingarrangementsnotfulfillingtheias32criteriaforoffsettingfinancialinstruments": -171000000,
    "netexposure": 30000000,
    "shorttermleaseslowvalueassetleasesandleasecontractscommittedbutnotstartedyet": 221000000,
    "irrevocablepurchasecommitmentsgiven": 6141000000,
    "irrevocablepurchasecommitmentsreceived": 550000000,
    "commitmentsrelatedtoresearchanddevelopmentlicenseagreementsothercommitments": 381000000,
    "commitmentsrelatedtoresearchanddevelopmentlicenseagreementscontingentmilestonepaymentsinconnectionwithdevelopmentprogramsinprogress": 4886000000,
    "totaloffbalancesheetcommitments": 11079000000,
    "leaseterm": "P15Y",
    "commitmentsrelatedtoresearchanddevelopmentrelatingtoprojectsinresearchphase": 16800000000,
    "commitmentsrelatedtoresearchanddevelopmentpaymentscontingentuponattainmentofsalestargets": 17900000000,
    "commitmentsrelatedtocollaborationdiscoverydevelopmentandcommercializationagreements": 10000000000,
    "commitmentsrelatedtoattainmentofregulatoryandsalesmilestonesforcommercializedproducts": 8500000000,
    "commitmentsreceivedfordevelopmentcosts": 2100000000,
    "cumulativedevelopmentcostsincurred": 8600000000,
    "undrawnborrowingfacilities": 8000000000,
    "estimatedfinancialeffectofcontingentliabilities": 3936000000,
    "numberofcivilindividualactions": 180,
    "numberofongoinglawsuits": 6,
    "numberofplaintiffs": 6770,
    "numberofindividualcasessettled": 100,
    "numberofcomplaintsfiled": 3280,
    "numberofclassactionlawsuits": 7,
    "numberofongoingtrials": 6,
    "numberofpeopleexposed": 133,
    "numberoflawsuitsruledonmerit": 30,
    "numberoffamilieswhofiledacivilclaim": 11,
    "numberofpreactionprotocolcases": 2,
    "numberofcivilclaimsongoing": 2,
    "numberofcases": 8,
    "numberofmanufacturerswithmarketingauthorizationforgenericversionofdrug": 8,
    "numberofpatentscoveringproduct": 4,
    "reducedamountofcompensationclaimedbyfilledplaintiffs": 223300000,
    "reducedamountofcompensationclaimedbyfilledplaintiffsinterestincluded": 360500000,
    "provisionsfordiscountsrebatesandsalesreturns": 2962000000,
    "increasedecreasethroughchangesinscopeofconsolidationinprovisionfordiscountsrebatesandsalesreturns": 2000000,
    "increasethroughnewprovisionrelatedtocurrentperiodsales": 7758000000,
    "increasedecreaseinprovisionsrelatedtopriorperiodsales": -74000000,
    "decreasethroughpaymentsmadeprovisionsfordiscountsrebatesandsalesreturns": 7251000000,
    "increasedecreasethroughnetexchangedifferencesprovisionsfordiscountsrebatesandsalesreturns": -76000000,
    "wagesandsalaries": 7183000000,
    "socialsecuritycontributions": 2100000000,
    "otheremployeeexpense": 531000000,
    "employeebenefitsexpense": 9814000000,
    "numberofemployees": 87994,
    "gainsondivestmentofproducts": 688000000,
    "miscellaneousotheroperatingincomeexpenses": 217000000,
    "expenseofrestructuringactivitiesemployeerelatedexpenses": 489000000,
    "expenseofrestructuringactivitiesrelatedtopropertyplantandequipmentandtoinventories": 293000000,
    "expenseofrestructuringactivitiestransformationprogramscosts": 676000000,
    "otherrestructuringcost": 32000000,
    "increasedecreaseinexpenseofrestructuringactivities": 154000000,
    "interestexpenseonborrowings": 555000000,
    "interestincome": 533000000,
    "costofdebtnet": 22000000,
    "nonoperatingforeignexchangegainslosses": -2000000,
    "expenseduetounwindingofdiscountonprovisions": 59000000,
    "netinterestcostrelatedtoemployeebenefits": 73000000,
    "gainslossesonavailableforsalefinancialassets": -1000000,
    "interestexpenseonleaseliabilities": 39000000,
    "otherfinanceincomecost": -526000000,
    "financeincomecost": -722000000,
    "gainslossesonderivativesusedtomanagedebt": -67000000,
    "gainslossesonderivativesusedtomanagecashandcashequivalents": -13000000,
    "liabilityrecognisedforestimatedfutureroyalties": 541000000,
    "currenttaxexpenseincome": 2560000000,
    "applicabletaxrate": 0.258,
    "taxrateeffectofforeigntaxrates": -0.136,
    "taxrateeffectofrevisionstotaxexposuresandsettlementsoftaxdisputes": 0.027,
    "taxrateeffectofreversaloftemporarydifferenceoninvestments": 0.051,
    "taxrateeffectoffairvalueremeasurementofcontingentconsiderations": 0.001,
    "othertaxrateeffectsforreconciliationbetweenaccountingprofitandtaxexpenseincome": 0.023,
    "shareofprofitlossofassociatesandjointventuresaccountedforusingequitymethod": -115000000,
    "numberofexecutivecommitteemembers": 10,
    "keymanagementpersonnelcompensationshorttermemployeebenefits": 36000000,
    "keymanagementpersonnelcompensationpostemploymentbenefits": 2000000,
    "keymanagementpersonnelcompensationsharebasedpayment": 8000000,
    "keymanagementpersonnelcompensation": 46000000,
    "aggregatepensionobligationinfavorofcertaincorporateofficersandofmembersoftheexecutivecommittee": 10000000,
    "keymanagementpersonnelcompensationterminationbenefitsandlumpsumretirementbenefits": 6000000,
    "percentageofentitysrevenue": 0.27,
    "businessoperatingincome": 11247000000,
    "amortizationandimpairmentofintangibleassetsotherthangoodwill": 3068000000,
    "expensearisingfromtheimpactofacquisitionsoninventories": 20000000,
    "investmentsinassociatesandjointventures": 234000000,
    "purchaseofpropertyplantandequipmentclassifiedasinvestingactivities": 1619000000,
    "purchaseofintangibleassetsclassifiedasinvestingactivities": 1287000000,
    "auditorsremunerationforauditservices": 15100000,
    "servicesotherthanstatutoryaudit": 5400000,
    "auditorsremunerationforauditrelatedservices": 5300000,
    "auditorsremunerationforotherservices": 100000,
    "auditorsremuneration": 20500000,
    "percentageofauditorremunerationforstatutoryaudit": 0.74,
    "percentageofauditorsremunerationforservicesotherthanauditoffinancialstatements": 0.26,
    "percentageofauditorsremuneration": 1,
    "auditofthefinancialstatementsoftheparentcompanyanditsfrenchsubsidiaries": 7900000,
    "auditrelatedserviceschargedtotheparentcompanyanditsfrenchsubsidiaries": 5200000,
    "auditorsremunerationforauditrelatedservicescomfortlettersandattestationservices": 500000,
    "proportionofownershipinterestinjointoperation": 0.117
  }
]